应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06990 科伦博泰生物-B
休市中 07-26 16:08:20
149.300
-0.600
-0.40%
最高
153.200
最低
147.500
成交量
16.60万
今开
150.500
昨收
149.900
日振幅
3.80%
总市值
332.71亿
流通市值
194.50亿
总股本
2.23亿
成交额
2,485万
换手率
0.13%
流通股本
1.30亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科伦博泰生物-B07月25日遭主力抛售307万元 环比增加132.58%
自选股智能写手 · 07-25 16:16
科伦博泰生物-B07月25日遭主力抛售307万元 环比增加132.58%
科伦博泰生物-B(06990)认购成都银行本金额为2.5亿元的结构性存款
智通财经网 · 07-24
科伦博泰生物-B(06990)认购成都银行本金额为2.5亿元的结构性存款
科伦博泰生物-B(06990.HK)认购2.5亿元结构性存款
格隆汇资讯 · 07-24
科伦博泰生物-B(06990.HK)认购2.5亿元结构性存款
国君晨报0724|交运、新股、科伦博泰生物-B、军工
国泰君安证券研究 · 07-24
国君晨报0724|交运、新股、科伦博泰生物-B、军工
【券商聚焦】国泰君安首予科伦博泰生物(06990)“增持”评级 料旗下核心品种陆续步入收获期 潜在催化剂充足
金吾财讯 · 07-23
【券商聚焦】国泰君安首予科伦博泰生物(06990)“增持”评级 料旗下核心品种陆续步入收获期 潜在催化剂充足
国泰君安:首予科伦博泰生物-B“增持”评级 目标价198.43港元
新浪港股 · 07-23
国泰君安:首予科伦博泰生物-B“增持”评级 目标价198.43港元
科伦博泰生物-B(06990)锋芒初显,中国ADC龙头逐鹿全球市场
国泰君安 · 07-23
科伦博泰生物-B(06990)锋芒初显,中国ADC龙头逐鹿全球市场
科伦博泰生物-B07月22日遭主力抛售339万元 环比增加245.92%
自选股智能写手 · 07-22
科伦博泰生物-B07月22日遭主力抛售339万元 环比增加245.92%
科伦博泰生物-B(06990)上涨5.11%,报156.3元/股
金融界 · 07-22
科伦博泰生物-B(06990)上涨5.11%,报156.3元/股
科伦博泰生物-B(06990)股价上升5.044%,现价港币$156.2
阿斯达克财经 · 07-22
科伦博泰生物-B(06990)股价上升5.044%,现价港币$156.2
科伦博泰生物-B(06990)出现大手买入5万股,成交价$149.3,涉资746.5万
阿斯达克财经 · 07-19
科伦博泰生物-B(06990)出现大手买入5万股,成交价$149.3,涉资746.5万
平安证券:核药具有多重临床优势 高壁垒造就寡头垄断格局
智通财经 · 07-18
平安证券:核药具有多重临床优势 高壁垒造就寡头垄断格局
科伦博泰生物-B07月18日遭主力抛售127万元 环比增加159.18%
自选股智能写手 · 07-18
科伦博泰生物-B07月18日遭主力抛售127万元 环比增加159.18%
科伦博泰生物-B(06990)出现大手成交20.53万股,成交价$143.48,涉资2.946千万
阿斯达克财经 · 07-18
科伦博泰生物-B(06990)出现大手成交20.53万股,成交价$143.48,涉资2.946千万
港股异动 | 科伦博泰生物-B(06990)再涨超5% 解禁后股价连续反弹 机构指其ADC领域研发实力强劲
智通财经 · 07-17
港股异动 | 科伦博泰生物-B(06990)再涨超5% 解禁后股价连续反弹 机构指其ADC领域研发实力强劲
科伦博泰生物-B(06990)上涨5.21%,报157.5元/股
金融界 · 07-17
科伦博泰生物-B(06990)上涨5.21%,报157.5元/股
科伦博泰生物-B(06990)股价上升5.01%,现价港币$157.2
阿斯达克财经 · 07-17
科伦博泰生物-B(06990)股价上升5.01%,现价港币$157.2
【港股通】科伦博泰生物(06990)涨3.74% 机构指其ADC研发实力强 有望受益于创新药政策支持
金吾财讯 · 07-17
【港股通】科伦博泰生物(06990)涨3.74% 机构指其ADC研发实力强 有望受益于创新药政策支持
【券商聚焦】国金证券首予科伦博泰生物(06990)“买入”评级 指其ADC领域研发实力强劲
金吾资讯 · 07-16
【券商聚焦】国金证券首予科伦博泰生物(06990)“买入”评级 指其ADC领域研发实力强劲
科伦博泰生物-B07月16日主力资金流出55万元 连续3日减仓
自选股智能写手 · 07-16
科伦博泰生物-B07月16日主力资金流出55万元 连续3日减仓
公司概况
公司名称:
科伦博泰生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。该公司主要从事生物药品、化学药品原料、化学药品制剂的研发、生产和销售。该公司的产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。
发行价格:
--
{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":149.3,"timestamp":1721981300031,"preClose":149.9,"halted":0,"volume":166000,"delay":0,"floatShares":130273005,"shares":222844099,"eps":-3.0584629,"marketStatus":"休市中","marketStatusCode":7,"change":-0.6,"latestTime":"07-26 16:08:20","open":150.5,"high":153.2,"low":147.5,"amount":24851160,"amplitude":0.038025,"askPrice":149.3,"askSize":100,"bidPrice":147.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.058462879807016,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"listingDate":1689004800000,"adjPreClose":149.9,"openAndCloseTimeList":[[1721957400000,1721966400000],[1721970000000,1721980800000]],"volumeRatio":0.4420711086459273,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990/wiki","defaultTab":"wiki","newsList":[{"id":"2454845454","title":"科伦博泰生物-B07月25日遭主力抛售307万元 环比增加132.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454845454","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454845454?lang=zh_cn&edition=full","pubTime":"2024-07-25 16:16","pubTimestamp":1721895419,"startTime":"0","endTime":"0","summary":"07月25日, 科伦博泰生物-B股价跌0.53%,报收149.90元,成交金额5055万元,换手率0.26%,振幅6.04%,量比0.61。科伦博泰生物-B今日主力资金净流出307万元,上一交易日主力净流出132万元,今日环比增加132.58%。该股近5个交易日下跌0.60%,主力资金累计净流出1010万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1779万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251618149ee9205c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251618149ee9205c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2453700775","title":"科伦博泰生物-B(06990)认购成都银行本金额为2.5亿元的结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2453700775","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453700775?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:29","pubTimestamp":1721827796,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990)发布公告,于2024年7月9日及2024年7月24日...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_1.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_1.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06990","LU0196878994.USD","601838","BK0278","BK1161"],"gpt_icon":0},{"id":"2453000460","title":"科伦博泰生物-B(06990.HK)认购2.5亿元结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2453000460","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453000460?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:29","pubTimestamp":1721827788,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨科伦博泰生物-B(06990.HK)公告,于2024年7月9日及2024年7月24日,公司分别订立成都银行结构性存款协议I及成都银行结构性存款协议II,据此,公司同意向成都银行分别认购本金额为人民币50百万元及人民币200百万元的两笔结构性存款。于本公告日期,存置于成都银行的结构性存款未偿还本金总额为人民币250百万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242129569ee650f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242129569ee650f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2453094255","title":"国君晨报0724|交运、新股、科伦博泰生物-B、军工","url":"https://stock-news.laohu8.com/highlight/detail?id=2453094255","media":"国泰君安证券研究","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453094255?lang=zh_cn&edition=full","pubTime":"2024-07-24 06:58","pubTimestamp":1721775535,"startTime":"0","endTime":"0","summary":"维持油运增持评级。2024年2季度打新基金产品收益持续正贡献。24Q2打新基金持仓A股股票717亿,和24Q1相比股票规模增加了5%。打新基金在24Q2增持电子和通信,减持食品饮料最为明显。从具体增持行业来看,增持靠前行业为电子、通信、机械设备、国防军工、环保,减持靠前的行业为食品饮料、有色金属、纺织服饰、公用事业、汽车。科伦博泰生物-B锋芒初显,中国ADC龙头逐鹿全球市场首次覆盖,给予增持评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072407004595543997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072407004595543997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2453701985","title":"【券商聚焦】国泰君安首予科伦博泰生物(06990)“增持”评级 料旗下核心品种陆续步入收获期 潜在催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2453701985","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453701985?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:22","pubTimestamp":1721719366,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰君安发研报指,科伦博泰生物 多款ADC管线与全球制药巨头默沙东开展密切合作,其中SKB264已成为默沙东在肿瘤领域的关键资产,已陆续启动10项关键临床试验。此外,旗下核心品种陆续步入收获期,潜在催化剂充足。首次覆盖,给予“增持”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940903","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","02611"],"gpt_icon":0},{"id":"2453705786","title":"国泰君安:首予科伦博泰生物-B“增持”评级 目标价198.43港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453705786","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453705786?lang=zh_cn&edition=full","pubTime":"2024-07-23 14:54","pubTimestamp":1721717640,"startTime":"0","endTime":"0","summary":" 国泰君安发布研究报告称,首次覆盖科伦博泰生物-B,给予“增持”评级,预计2024-2026年收入11.81/15.74/23.61亿元,目标价198.43港元。公司具有业内领先的药物开发技术平台,尤以ADC见长,构建了丰富的创新药研发管线,核心产品加速步入收获期。公司为国内ADC药物龙头,核心品种陆续步入收获期。 SKB264具备全球同类最佳潜力,背靠默沙东,市场潜力巨大。 ADC为肿瘤领域的行业风口,SKB264展现同类最佳潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2024-07-23/doc-incfcarc0337047.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2024-07-23/doc-incfcarc0337047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02611","06990"],"gpt_icon":0},{"id":"2453977627","title":"科伦博泰生物-B(06990)锋芒初显,中国ADC龙头逐鹿全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2453977627","media":"国泰君安","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453977627?lang=zh_cn&edition=full","pubTime":"2024-07-23 11:14","pubTimestamp":1721704468,"startTime":"0","endTime":"0","summary":"首次覆盖,给予“增持”评级。ADC为肿瘤领域的行业风口,SKB264展现同类最佳潜力。背靠默沙东,横跨乳腺癌与肺癌两大市场。公司多款ADC管线与全球制药巨头默沙东开展密切合作,其中SKB264已成为默沙东在肿瘤领域的关键资产,已陆续启动10项关键临床试验。临床试验进展不及预期风险;新药研发失败风险;市场推广及销售不及预期风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231200249551a714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407231200249551a714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2453842755","title":"科伦博泰生物-B07月22日遭主力抛售339万元 环比增加245.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453842755","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453842755?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:16","pubTimestamp":1721636195,"startTime":"0","endTime":"0","summary":"07月22日, 科伦博泰生物-B股价涨5.92%,报收157.50元,成交金额9868万元,换手率0.49%,振幅9.01%,量比1.04。科伦博泰生物-B今日主力资金净流出339万元,连续7日净流出,上一交易日主力净流出98万元,今日环比增加245.92%。该股近5个交易日上涨4.40%,主力资金累计净流出666万元;近20日主力资金累计净流入2192万元,其中净流入天数为7日。该股主力净额占比0.02%,港股市场排名2533/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221617079ede5c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221617079ede5c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2453789225","title":"科伦博泰生物-B(06990)上涨5.11%,报156.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453789225","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453789225?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:45","pubTimestamp":1721616327,"startTime":"0","endTime":"0","summary":"7月22日,科伦博泰生物-B(06990)盘中上涨5.11%,截至10:45,报156.3元/股,成交2301.52万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司,主要以抗体药物偶联物(ADC)的技术平台为基础,致力于解决全球普遍或难以治疗的癌症以及众多患人医疗需求未满足的其他疾病。公司拥有完善的一体化药物开发机制,已建立包含研发、生产、质量控制及商业化等全面功能的一体化能力,并有30多款差异化且具有临床价值的资产管线,其中10余款处于临床阶段。截至2023年年报,科伦博泰生物-B营业总收入15.4亿元、净利润-5.74亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/22104541702176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2453813197","title":"科伦博泰生物-B(06990)股价上升5.044%,现价港币$156.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2453813197","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453813197?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:45","pubTimestamp":1721616300,"startTime":"0","endTime":"0","summary":"[上升股]科伦博泰生物-B(06990) 股价在上午10:45比前收市价上升5.044%,现股价为港币$156.2。至目前为止,今日最高价为$156.2,而最低价为$146.2。总成交量为14.74万股,总成交金额为港币$2.252千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407221090/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2452493964","title":"科伦博泰生物-B(06990)出现大手买入5万股,成交价$149.3,涉资746.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2452493964","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452493964?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:35","pubTimestamp":1721352900,"startTime":"0","endTime":"0","summary":"[大手成交]科伦博泰生物-B(06990)在上午09:35出现大手买入,成交量为5万,成交价为港币$149.3,涉资746.5万。至目前为止,股价跌1.2%,今日最高价为$150.0,而最低价为$148.0,总成交量为5.811万股,总成交金额港币$867.353万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT240719553/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2452485935","title":"平安证券:核药具有多重临床优势 高壁垒造就寡头垄断格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2452485935","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452485935?lang=zh_cn&edition=full","pubTime":"2024-07-18 20:31","pubTimestamp":1721305897,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,平安证券发布研究报告称,截止2024年7月4日,全球有88款放射性新药获批上市,仅有18款用于治疗。平安证券观点如下:核药应用于临床诊断和治疗,具有多重优势:放射性核素指原子核不稳定,在衰变成其他核素时会自发性地放出电离辐射的核素, 用其制成的特殊制剂为放射性药物,也称核药。1)核素生产阶段:反应堆辐照为放射性核素主要生产方式,具有极高资金、建设和审批壁垒,因此上游核素供应商对下游有强话语权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU0196878994.USD","BK1161","BK1222","00512","01763","BK1191","161027"],"gpt_icon":0},{"id":"2452171844","title":"科伦博泰生物-B07月18日遭主力抛售127万元 环比增加159.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452171844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452171844?lang=zh_cn&edition=full","pubTime":"2024-07-18 16:15","pubTimestamp":1721290537,"startTime":"0","endTime":"0","summary":"07月18日, 科伦博泰生物-B股价跌3.60%,报收150.00元,成交金额1.80亿元,换手率0.93%,振幅5.27%,量比1.24。科伦博泰生物-B今日主力资金净流出127万元,连续5日净流出,上一交易日主力净流出49万元,今日环比增加159.18%。该股近5个交易日上涨5.49%,主力资金累计净流出499万元;近20日主力资金累计净流入2055万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816155495d42c40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816155495d42c40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2452489231","title":"科伦博泰生物-B(06990)出现大手成交20.53万股,成交价$143.48,涉资2.946千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2452489231","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452489231?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:00","pubTimestamp":1721264400,"startTime":"0","endTime":"0","summary":"[大手成交]科伦博泰生物-B(06990)在上午09:00出现大手成交,成交量为20.53万,成交价为港币$143.48,涉资2.946千万。至目前为止,股价无升跌,今日最高价为$143.48,而最低价为$143.48,总成交量为59.214万股,总成交金额港币$8.496千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2407183/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2452356185","title":"港股异动 | 科伦博泰生物-B(06990)再涨超5% 解禁后股价连续反弹 机构指其ADC领域研发实力强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2452356185","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452356185?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:00","pubTimestamp":1721199608,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科伦博泰生物-B午后再涨超5%,截至发稿,涨4.88%,报157港元,成交额1.06亿港元。7月11至今,该股累计涨幅已超18%。消息面上,科伦博泰生物上市届满一年,7月12日迎来超1亿股H股解禁。以上ADC产品临床试验的顺利推进均再次印证公司在ADC领域的强劲研发实力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","ADC","BK1161","YANG","BK4231","LU0196878994.USD","HSCEI","BK4080","HSTECH"],"gpt_icon":1},{"id":"2452718331","title":"科伦博泰生物-B(06990)上涨5.21%,报157.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452718331","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452718331?lang=zh_cn&edition=full","pubTime":"2024-07-17 14:39","pubTimestamp":1721198373,"startTime":"0","endTime":"0","summary":"7月17日,科伦博泰生物-B盘中上涨5.21%,截至14:39,报157.5元/股,成交9309.14万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司,主要以抗体药物偶联物的技术平台为基础,致力于解决全球普遍或难以治疗的癌症以及众多患人医疗需求未满足的其他疾病。截至2023年年报,科伦博泰生物-B营业总收入15.4亿元、净利润-5.74亿元。7月16日,国金证券首次给予买入评级,目标价202.66港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/17143941616219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2452183181","title":"科伦博泰生物-B(06990)股价上升5.01%,现价港币$157.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2452183181","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452183181?lang=zh_cn&edition=full","pubTime":"2024-07-17 14:39","pubTimestamp":1721198340,"startTime":"0","endTime":"0","summary":"[上升股]科伦博泰生物-B(06990) 股价在下午02:39比前收市价上升5.01%,现股价为港币$157.2。至目前为止,今日最高价为$157.2,而最低价为$148.9。总成交量为60.348万股,总成交金额为港币$9.282千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407171252/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2452077669","title":"【港股通】科伦博泰生物(06990)涨3.74% 机构指其ADC研发实力强 有望受益于创新药政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452077669","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452077669?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:58","pubTimestamp":1721195923,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科伦博泰生物 股价走高,截止发稿,涨3.74%,报155.3港元,成交额7606.15万港元。以上ADC产品临床试验的顺利推进均再次印证公司在ADC领域的强劲研发实力。首次覆盖,给予“买入”评级。东吴证券表示,《全链条支持创新药发展实施方案》具体条款有望近期落地,叠加创新药板块处于历史相对底部位置,下半年有ESMO大会、WCLC大会、医保谈判、创新药出海预期等多重催化,创新药板块有望走强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZDVjZjI4MzkxNjI4NTkwMDQ5NTQ5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDVjZjI4MzkxNjI4NTkwMDQ5NTQ5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940551","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","HSCEI","LU0196878994.USD","BK1161","HSTECH","06990","BK1574","06978","BK4231","BK4080","159992","YANG"],"gpt_icon":1},{"id":"2451196548","title":"【券商聚焦】国金证券首予科伦博泰生物(06990)“买入”评级 指其ADC领域研发实力强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2451196548","media":"金吾资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451196548?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:22","pubTimestamp":1721121737,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国金证券发研指,科伦博泰生物 为国内TROP2ADC领军者,先发优势明显:目前全球仅有三款靶向TROP2的抗体偶联药物推进至注册或上市阶段,其中SKB264有望成为首款国产上市的TROP2ADC。该行指,公司与默沙东分别于2022、2023年达成三项涉及ADC资产的合作协议,据公司公告披露,三项合作协议前期及里程碑付款有望超百亿美元。以上ADC产品临床试验的顺利推进均再次印证公司在ADC领域的强劲研发实力。首次覆盖,给予“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071617224195c68021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071617224195c68021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990"],"gpt_icon":0},{"id":"2451575699","title":"科伦博泰生物-B07月16日主力资金流出55万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2451575699","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451575699?lang=zh_cn&edition=full","pubTime":"2024-07-16 16:16","pubTimestamp":1721117797,"startTime":"0","endTime":"0","summary":"07月16日, 科伦博泰生物-B股价跌0.20%,报收149.70元,成交金额3656万元,换手率0.19%,振幅4.80%,量比0.25。科伦博泰生物-B今日主力资金净流出55万元,连续3日净流出,上一交易日主力净流出225万元,今日环比减少75.56%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为3.58%。该股近5个交易日上涨3.38%,主力资金累计净流入3138万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1953万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616170195c61fd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616170195c61fd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":-0.1033},{"period":"3month","weight":-0.1113},{"period":"6month","weight":0.7669},{"period":"1year","weight":0.878},{"period":"ytd","weight":0.4509}],"compareEarnings":[{"period":"1week","weight":-0.0228},{"period":"1month","weight":-0.0591},{"period":"3month","weight":-0.0357},{"period":"6month","weight":0.067},{"period":"1year","weight":-0.1333},{"period":"ytd","weight":-0.0015}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。该公司主要从事生物药品、化学药品原料、化学药品制剂的研发、生产和销售。该公司的产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。","exchange":"SEHK","name":"科伦博泰生物-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦博泰生物-B,06990,科伦博泰生物-B股票,科伦博泰生物-B股票老虎,科伦博泰生物-B股票老虎国际,科伦博泰生物-B行情,科伦博泰生物-B股票行情,科伦博泰生物-B股价,科伦博泰生物-B股市,科伦博泰生物-B股票价格,科伦博泰生物-B股票交易,科伦博泰生物-B股票购买,科伦博泰生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}